PSMA-Negative Lesion Progression Under 177Lu-PSMA Radioligand Therapy

被引：2
|
作者：
Murthy, Vishnu [1 ]
Allen-Auerbach, Martin [1 ]
Lam, Richard [2 ]
Owen, Dawn [3 ]
Czernin, Johannes [1 ]
Calais, Jeremie [1 ]
机构：
[1] Univ Calif Los Angeles, David Geffen Sch Med, Ahmanson Translat Theranost Div, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[2] Prostate Oncol Specialists, Marina Del Rey, CA USA
[3] Mayo Clin, Dept Radiat Oncol, Rochester, MN USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷 / 09期
关键词：
D O I：
10.2967/jnumed.122.265099
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
[No abstract available]
引用
收藏
页码：1502 / 1503
页数：2
相关论文
共 50 条
  • [1] 177Lu-PSMA Radioligand Therapy for Prostate Cancer
    Fendler, Wolfgang P.
    Rahbar, Kambiz
    Herrmann, Ken
    Kratochwil, Clemens
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (08) : 1196 - 1200
  • [2] Assessing Response to 177Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria
    Michalski, Kerstin
    Klein, Claudius
    Brueggemann, Tonio
    Meyer, Philipp T.
    Jilg, Cordula Annette
    Ruf, Juri
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (12) : 1741 - 1746
  • [3] Long-Term Nephrotoxicity of 177Lu-PSMA Radioligand Therapy
    Steinhelfer, Lisa
    Lunger, Lukas
    Cala, Lisena
    Pfob, Christian H.
    Lapa, Constantin
    Hartrampf, Philipp E.
    Buck, Andreas K.
    Schaefer, Hannah
    Schmaderer, Christoph
    Tauber, Robert
    Brosch-Lenz, Julia
    Haller, Bernhard
    Meissner, Valentin H.
    Knorr, Karina
    Weber, Wolfgang A.
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (01) : 79 - 84
  • [4] Radiation levels outside a patient undergoing 177Lu-PSMA radioligand therapy
    Li, Huan
    Liu, Haikuan
    Zhang, Weiyuan
    Lin, Xin
    Li, Zhiling
    Zhuo, Weihai
    JOURNAL OF RADIOLOGICAL PROTECTION, 2024, 44 (02)
  • [5] Pre- or Post-Chemotherapy: Effect of 177Lu-PSMA Radioligand Therapy on PSMA Expression
    Yadav, Surekha
    Heath, Courtney Lawhn
    Juarez, Roxanna
    De Kouchkovsky, Ivan
    Aggarwal, Rahul
    Hope, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [6] Dosimetry of 177Lu-PSMA
    Serrano, B.
    Amblard, R.
    Koulibaly, P. M.
    Gasteuil, J.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2023, 47 (06): : 323 - 332
  • [7] PSMA PET/CT for Response Assessment of 177Lu-PSMA Therapy
    Hartrampf, Philipp E.
    Serfling, Sebastian E.
    Michalski, Kerstin
    Buck, Andreas K.
    Werner, Rudolf A.
    SEMINARS IN NUCLEAR MEDICINE, 2024, 54 (01) : 69 - 76
  • [8] 177Lu-PSMA radio-ligand therapy
    Chanchou, M.
    Giraudet, A. L.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2023, 47 (06): : 316 - 322
  • [9] 177Lu-PSMA radioligand therapy for isolated bilateral adrenal metastases from prostate cancer
    Perrone, Elisabetta
    Ghai, Kriti
    Eismant, Aleksandr
    Konz, Kornelia
    Baum, Richard P.
    ACTA ONCOLOGICA, 2024, 63 : 557 - 562
  • [10] 177Lu-PSMA Radioligand Therapy for Prostate Cancer (vol 58, pg 1196, 2017)
    Fendler
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (02) : 346 - 346
12345